Danaher gets conditional S.Korean regulatory nod for $21 bln GE biopharma unit deal
February 03, 2020 at 22:00 PM EST
South Korea's antitrust watchdog has approved Danaher Corp's proposed $21.4 billion acquisition of General Electric's biopharma division on condition that they sell certain assets to address monopoly concerns.